Thermo Fisher Scientific Inc (TMO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry and synthetic biology. The companys product portfolio includes technologies for mass spectrometry, electron microscopy, genetic sequencing, protein and molecular biology research. The company serves pharmaceutical and biotech companies, academic and research institutions, clinical diagnostic labs, and government agencies; and environmental, industrial quality and process control sectors. It sells its products and services through direct sales force, e-commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Waltham, Massachusetts, the US.

Thermo Fisher Scientific Inc (TMO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 8
List of Figures 10
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 11
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 12
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 13
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 14
Thermo Fisher Scientific Inc, Medical Devices Deals, 2012 to YTD 2018 15
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 16
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deal Details 21
Asset Purchase 21
Patheon Acquires API Manufacturing Site, South Carolina from Roche 21
Venture Financing 22
IntegenX Secures USD10 Million in Financing 22
IntegenX Raises US$49 Million In Venture Financing 23
Private Equity 24
GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 24
StoneCalibre Acquires Anatrace From Affymetrix 25
OpenGate Capital Acquires Laboratory Workstations Business From Thermo Fisher 26
Partnerships 27
Affymetrix Enters into Licensing Agreement with Peptide Groove 27
diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 28
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 29
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 30
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 31
Genomics England, Inivata and Thermo Fisher Enter into Agreement 32
Synthego Enters into Agreement with Thermo Fisher 33
Thermo Fisher Scientific Partners with National Institute for Bioprocessing Research and Training 34
Thermo Fisher Scientific Enters into Agreement with West China Hospital of Sichuan University 35
Achaogen Enters into Agreement with Microgenics 36
Patheon Enters into Co-Development Agreement with Grunenthal 37
Thermo Fisher Scientific Enters into Agreement with Karolinska Institute 38
Singapore General Hospital Enters into Agreement with Thermo Fisher Scientific 39
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 40
Horizon Discovery Enters into Agreement with Thermo Fisher Scientific 41
Horizon Discovery Enters Into Marketing Agreement With Thermo Fisher 42
AstraZeneca Enters into Research Agreement with Thermo Fisher Scientific 43
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 44
Affymetrix Enters Into Integration Agreement With CollabRx 45
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 46
Life Technologies Enters Into Distribution Agreement With IntegenX For GlobalFiler Express Chemistry 47
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 48
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 49
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 50
Thermo Fisher Scientific Enters Into Distribution Agreement With Mitsui Knowledge Industry For Lipidomics Software 51
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 52
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 53
Olfactory Biosciences Enters Into Distribution Agreement With Fisher HealthCare For Noxo Products 54
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 55
Affymetrix Enters Into Co-Marketing Agreement With GenoSplice For GeneChip Human Transcriptome Array 2.0 56
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 57
Affymetrix Enters Into Research Agreement With Centre For Proteomic And Genomic Research 58
Genedata Enters Into Technology Integration Agreement With Life Technologies 59
Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 60
Life Technologies Enters Into Distribution Agreement With Sino Biological 61
Thermo Fisher Enters Into An Agreement With Princeton University 62
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 63
Refine Technology Enters Into Technology Integration Agreement With Thermo Fisher Scientific 64
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 65
Life Technologies Enters Into Co-Development Agreement With Boston Childrens Hospital 66
Life Technologies Enter Into Agreement With University Of North Texas Health Science Center For DNA Analyses 67
Hospital for Sick Children Enters Into Co-Development Agreement With Life Technologies 68
Life Technologies Amends Co-Marketing Agreement With Cellular Dynamics International 69
Life Technologies Enters Into Co-Development Agreement With OpGen 70
Almac Enters Into Distribution Agreement With Affymetrix For Xcel Array 71
Partek Enters Into Technology Integration Agreement With Life Technologies 72
FEI Enters Into R&D Agreement With NIH 73
Thermo Fisher Scientific Enters Into Co-Marketing Agreement With PREMIER Biosoft 74
Licensing Agreements 75
Juno Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 75
Life Technologies Enters into Licensing Agreement with Genovis 76
Adaptimmune Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 77
MabVax Therapeutics Enters into Licensing Agreement with Life Technologies 78
Cellectis Enters into Licensing Agreement with Thermo Fisher Scientific for Gene Editing Technology 79
Life Technologies Enters Into Licensing Agreement With Suzhou Ribo Life Sciences For siRNA Therapeutics 80
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 81
Thermo Fisher Scientific Enters into Licensing Agreement with Sygnis 82
Accellta Enters into Licensing Agreement with Thermo Fisher Scientific 83
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 84
BGI Enters Into Licensing Agreement With Life Technologies 85
Life Technologies Enters Into Licensing Agreement With iGenomics For Ion Proton Next-Generation Sequencers 86
Life Technologies Enters Into Licensing Agreement With Novartis 87
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 88
Cellular Dynamics International Enters Into Licensing Agreement With Life Technologies For TAL Effector Technology 89
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 90
Adaptimmune Enters Into Licensing Agreement With Life Technologies 91
Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 92
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 93
Life Technologies Enters Into Licensing Agreement With iPS Academia Japan 94
Cambridge Research Biochemicals Extends Licensing Agreement With Life Technologies 95
Equity Offering 96
Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 96
Patheon Completes IPO 98
Affymetrix to Raise USD50 Million in Private Placement of Shares 99
Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million 100
Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion 101
Patheon Completes Rights Offering Of Shares For US$30 Million 103
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 104
Debt Offering 105
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 105
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 107
Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 109
Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 111
Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 113
Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 115
Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 116
Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 117
Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 118
Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 120
Patheon Raises USD450 Million in Private Placement of 7.5% Notes Due 2022 122
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million 123
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion 125
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million 127
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million 129
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million 131
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million 133
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 135
Asset Transactions 137
Perrigo Acquires Mexican Operations of Patheon for USD34 Million 137
GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For US$1.06 Billion 138
Bellwyck Packaging Solutions Acquires Clinical Packaging And Distribution Services Business From Patheon 139
Acquisition 140
Thermo Fisher Scientific Acquires 99% Stake in Patheon for USD7.2 Billion 140
Thermo Fisher Scientific Acquires Finesse Solutions 142
Thermo Fisher Scientific Acquires MTI-GlobalStem 143
Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 144
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 146
LIVIA to Acquire Patheon Capua 147
Perrigo Company Acquires Banner Pharmacaps from Patheon for USD36.4 Million 148
Patheon Acquires IRIX Pharma 149
Patheon Acquires Agere Pharma 150
Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 151
JLL/Delta Patheon Completes Acquisition Of Patheon For US$2.6 Billion 152
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion 154
Life Technologies Acquires Life Science Korea, Instruments Distributor 157
Life Technologies Acquires BAC 158
Patheon Completes Acquisition Of Banner Pharmacaps From Vion For US$255 Million 159
Life Technologies Acquires Compendia Bioscience, Bioinformatics Company 161
Life Technologies Acquires Navigenics 162
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 163
Thermo Fisher Scientific Acquires Doe & Ingalls Management For US$175 Million 165
IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 166
Thermo Fisher Scientific Inc - Key Competitors 167
Thermo Fisher Scientific Inc - Key Employees 168
Thermo Fisher Scientific Inc - Locations And Subsidiaries 170
Head Office 170
Other Locations & Subsidiaries 170
Joint Venture 174
Recent Developments 175
Strategy And Business Planning 175
Jun 04, 2018: Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center 175
Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden 176
Financial Announcements 177
Apr 25, 2018: Thermo Fisher Scientific Reports First Quarter 2018 Results 177
Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results 179
Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 181
Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 184
Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 186
Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 188
Corporate Communications 190
Jun 24, 2018: Thermo Fisher Scientific Donates Rapid DNA Analysis Technology to Help Reunite Families Recently Separated at Border 190
Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 191
Legal and Regulatory 192
Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 192
Product News 193
Dec 07, 2017: New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes 193
Nov 27, 2017: Expanded Genome Editing Tool Kit Supports Every Step in Researchers Workflow 194
Oct 23, 2017: New Unrivalled Capabilities Take GC-MS to the Next Level of Performance 195
Oct 19, 2017: Thermo Fisher Scientific and Wellcome Trust Sanger Institute Announce the Axiom Africa Array for Medical and Population Genomics 196
Sep 25, 2017: Next-Generation Media System Provides the Highest In Vitro Survival of Neurons 197
Aug 07, 2017: Industrys First Dedicated Cryo-DualBeam System Automates Preparation of Frozen, Biological Samples 198
Aug 07, 2017: Thermo Fisher Scientific Advances Cryo-EM Leadership to Drive Structural Biology Discoveries 199
Aug 07, 2017: Thermo Fisher Scientifics New Talos F200i S/TEM Delivers Flexible, High-Performance Imaging 200
Jul 19, 2017: Thermo Fisher Scientific Announces Asia Precision Medicine Research Array for Regional Screening Initiatives 201
Jul 18, 2017: New Thermo Scientific Samco Leakproof Vials Offer Enhanced Sample and User Safety 202
Jul 11, 2017: New Universal RNase-, DNase- and Human DNA-free Containers Designed for Enhanced Sample Safety and Viability 203
Jun 20, 2018: New Thermo Scientific B R A H M S KRYPTOR GOLD Analyzer Instrument Combines Higher Throughput and Maximum Autonomy 204
Jun 18, 2018: Thermo Fisher Scientific Expands RNA Cells-to-CT Kits 205
Jun 18, 2018: Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology 206
Jun 05, 2017: Thermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ASMS 2017 207
Jun 05, 2017: New Tribrid Mass Spectrometer Delivers New Levels of Power and Performance for Protein and Small Molecule Characterization 209
Jun 05, 2017: Next-Generation Triple Quadrupole Mass Spectrometers Deliver High Precision for Quantitative Workflows 210
Jun 05, 2017: Ready-to-Use Mass Spectrometric Kit Simplifies Insulin Bioanalysis Workflows 211
Jun 05, 2017: New Software and Cloud-based Solutions Let Scientists Gain More Insight From Their Data 212
Jun 04, 2018: Advanced Autosampler and Liquid Handling System Improves Lab Productivity 213
Jun 04, 2018: New Consumables Improve Analytical Instrument Performance 214
May 15, 2017: Thermo Fisher Scientific Strengthens Portfolio of Endotoxin-Free Plasmid DNA Isolation Kits 215
May 03, 2017: Automating Blood Cell Washing Applications to Boost Laboratory Performance 216
Apr 17, 2018: Thermo Fisher Scientific Showcases Bioprocessing Workflow Solutions at INTERPHEX 217
Mar 15, 2017: Thermo Fisher Scientific Introduces the QuantStudio 5 Real-Time PCR System for the Modern Forensic Laboratory 218
Mar 15, 2017: Thermo Fisher Scientific Announces First-Ever Cloud-Based Application for Connectivity to Electronic Pipettes 219
Feb 28, 2018: Thermo Fisher Supplies Analytical Instruments to World Anti-Doping Agency Laboratory in South Korea 220
Feb 05, 2018: Thermo Fisher Scientific Launches Axiom Microbiome Array for Research 221
Feb 02, 2017: New Media Improves Performance in Latest Pluripotent Stem Cell Applications 222
Jan 29, 2018: New, Automated UV-Visible Spectrophotometers are Designed for Todays Modern Lab 223
Jan 08, 2018: Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research 224
Other Significant Developments 226
May 07, 2018: New Thermo Scientific Prisma SEM Combines Performance and Versatility 226
Apr 23, 2018: Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities 227
Mar 29, 2018: Thermo Fisher Scientific Sponsors Precision Medicine Summit in China 228
Mar 21, 2018: Thermo Fisher says UK job cuts not Brexit-related 229
Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities 230
Sep 27, 2017: Thermo Fisher Scientific to Participate in Capitol Hill Briefing on Precision Medicine Advancements 231
Jul 31, 2017: New Lab-Grade Undercounter Refrigerators Use Redundant Cooling Technology to Maintain Optimal Storage Conditions 232
Jul 10, 2017: Thermo Fisher Scientific and SRI International Collaborate to Enhance Small Molecule Research 233
Jun 15, 2017: Thermo Fisher Scientific Expands Access to Genome Editing with Hands-On Workshop 234
Appendix 235
Methodology 235
About GlobalData 235
Contact Us 235
Disclaimer 235

List Of Tables

List of Tables
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 11
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 12
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 13
Thermo Fisher Scientific Inc, Deals By Therapy Area, 2012 to YTD 2018 14
Thermo Fisher Scientific Inc, Medical Devices Deals, 2012 to YTD 2018 15
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 16
Patheon Acquires API Manufacturing Site, South Carolina from Roche 21
IntegenX Secures USD10 Million in Financing 22
IntegenX Raises US$49 Million In Venture Financing 23
GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 24
StoneCalibre Acquires Anatrace From Affymetrix 25
OpenGate Capital Acquires Laboratory Workstations Business From Thermo Fisher 26
Affymetrix Enters into Licensing Agreement with Peptide Groove 27
diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 28
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 29
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 30
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 31
Genomics England, Inivata and Thermo Fisher Enter into Agreement 32
Synthego Enters into Agreement with Thermo Fisher 33
Thermo Fisher Scientific Partners with National Institute for Bioprocessing Research and Training 34
Thermo Fisher Scientific Enters into Agreement with West China Hospital of Sichuan University 35
Achaogen Enters into Agreement with Microgenics 36
Patheon Enters into Co-Development Agreement with Grunenthal 37
Thermo Fisher Scientific Enters into Agreement with Karolinska Institute 38
Singapore General Hospital Enters into Agreement with Thermo Fisher Scientific 39
Stem Cell Theranostics Enters into Research Agreement with Thermo Fisher Scientific 40
Horizon Discovery Enters into Agreement with Thermo Fisher Scientific 41
Horizon Discovery Enters Into Marketing Agreement With Thermo Fisher 42
AstraZeneca Enters into Research Agreement with Thermo Fisher Scientific 43
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 44
Affymetrix Enters Into Integration Agreement With CollabRx 45
Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 46
Life Technologies Enters Into Distribution Agreement With IntegenX For GlobalFiler Express Chemistry 47
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 48
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 49
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 50
Thermo Fisher Scientific Enters Into Distribution Agreement With Mitsui Knowledge Industry For Lipidomics Software 51
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 52
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 53
Olfactory Biosciences Enters Into Distribution Agreement With Fisher HealthCare For Noxo Products 54
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 55
Affymetrix Enters Into Co-Marketing Agreement With GenoSplice For GeneChip Human Transcriptome Array 2.0 56
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 57
Affymetrix Enters Into Research Agreement With Centre For Proteomic And Genomic Research 58
Genedata Enters Into Technology Integration Agreement With Life Technologies 59
Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 60
Life Technologies Enters Into Distribution Agreement With Sino Biological 61
Thermo Fisher Enters Into An Agreement With Princeton University 62
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 63
Refine Technology Enters Into Technology Integration Agreement With Thermo Fisher Scientific 64
Life Technologies Enters Into Co-Marketing Agreement With Douglas Scientific 65
Life Technologies Enters Into Co-Development Agreement With Boston Childrens Hospital 66
Life Technologies Enter Into Agreement With University Of North Texas Health Science Center For DNA Analyses 67
Hospital for Sick Children Enters Into Co-Development Agreement With Life Technologies 68
Life Technologies Amends Co-Marketing Agreement With Cellular Dynamics International 69
Life Technologies Enters Into Co-Development Agreement With OpGen 70
Almac Enters Into Distribution Agreement With Affymetrix For Xcel Array 71
Partek Enters Into Technology Integration Agreement With Life Technologies 72
FEI Enters Into R&D Agreement With NIH 73
Thermo Fisher Scientific Enters Into Co-Marketing Agreement With PREMIER Biosoft 74
Juno Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 75
Life Technologies Enters into Licensing Agreement with Genovis 76
Adaptimmune Therapeutics Enters into Licensing Agreement with Thermo Fisher Scientific 77
MabVax Therapeutics Enters into Licensing Agreement with Life Technologies 78
Cellectis Enters into Licensing Agreement with Thermo Fisher Scientific for Gene Editing Technology 79
Life Technologies Enters Into Licensing Agreement With Suzhou Ribo Life Sciences For siRNA Therapeutics 80
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 81
Thermo Fisher Scientific Enters into Licensing Agreement with Sygnis 82
Accellta Enters into Licensing Agreement with Thermo Fisher Scientific 83
Thermo Fisher Enters into Licensing Agreement with ToolGen for CRISPR/Cas9 84
BGI Enters Into Licensing Agreement With Life Technologies 85
Life Technologies Enters Into Licensing Agreement With iGenomics For Ion Proton Next-Generation Sequencers 86
Life Technologies Enters Into Licensing Agreement With Novartis 87
Cellular Dynamics Enters Into Licensing Agreement With Life Technologies And Sigma-Aldrich 88
Cellular Dynamics International Enters Into Licensing Agreement With Life Technologies For TAL Effector Technology 89
Life Technologies Enters Into Licensing Agreement With ToolGen For TAL Effector Technology 90
Adaptimmune Enters Into Licensing Agreement With Life Technologies 91
Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 92
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 93
Life Technologies Enters Into Licensing Agreement With iPS Academia Japan 94
Cambridge Research Biochemicals Extends Licensing Agreement With Life Technologies 95
Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 96
Patheon Completes IPO 98
Affymetrix to Raise USD50 Million in Private Placement of Shares 99
Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million 100
Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion 101
Patheon Completes Rights Offering Of Shares For US$30 Million 103
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 104
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 105
Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 107
Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 109
Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 111
Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 113
Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 115
Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 116
Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 117
Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 118
Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 120
Patheon Raises USD450 Million in Private Placement of 7.5% Notes Due 2022 122
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million 123
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion 125
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million 127
Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million 129
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million 131
Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million 133
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 135
Perrigo Acquires Mexican Operations of Patheon for USD34 Million 137
GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For US$1.06 Billion 138
Bellwyck Packaging Solutions Acquires Clinical Packaging And Distribution Services Business From Patheon 139
Thermo Fisher Scientific Acquires 99% Stake in Patheon for USD7.2 Billion 140
Thermo Fisher Scientific Acquires Finesse Solutions 142
Thermo Fisher Scientific Acquires MTI-GlobalStem 143
Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 144
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 146
LIVIA to Acquire Patheon Capua 147
Perrigo Company Acquires Banner Pharmacaps from Patheon for USD36.4 Million 148
Patheon Acquires IRIX Pharma 149
Patheon Acquires Agere Pharma 150
Thermo Fisher Scientific Acquires Advanced Scientifics for USD289 Million 151
JLL/Delta Patheon Completes Acquisition Of Patheon For US$2.6 Billion 152
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion 154
Life Technologies Acquires Life Science Korea, Instruments Distributor 157
Life Technologies Acquires BAC 158
Patheon Completes Acquisition Of Banner Pharmacaps From Vion For US$255 Million 159
Life Technologies Acquires Compendia Bioscience, Bioinformatics Company 161
Life Technologies Acquires Navigenics 162
Affymetrix Completes Acquisition Of eBioscience For US$315 Million 163
Thermo Fisher Scientific Acquires Doe & Ingalls Management For US$175 Million 165
IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 166
Thermo Fisher Scientific Inc, Key Competitors 167
Thermo Fisher Scientific Inc, Key Employees 168
Thermo Fisher Scientific Inc, Subsidiaries 170
Thermo Fisher Scientific Inc, Joint Venture 174

List Of Figures

List of Figures
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 11
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 12
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 13
Thermo Fisher Scientific Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 14
Thermo Fisher Scientific Inc, Medical Devices Deals, 2012 to YTD 2018 15

2018 Diagnostics Competitive Intelligence: Thermo Fisher Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

Thermo Fisher: Performance, Capabilities, Goals and Strategies in the Global Diagnostics Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

2018 Diagnostics Competitive Intelligence: Thermo Fisher Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

Thermo Fisher: Performance, Capabilities, Goals and Strategies in the Global Diagnostics Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available